Quality Considerations remain paramount when evaluating treatment options
Children presenting neurological signs or symptoms, those unable to take oral medication, individuals with known malabsorption syndromes, infants under 6 months old, and patients using medications that may interfere with vitamin B12 absorption are typically treated with a parenteral protocol (1)
Breast feeding recommendation: compatible
After first-line treatments and diagnostics, including diet change, addition of probiotics, and fecal analysis, were performed, a GI panel determined serum cobalamin, folate, and trypsin-like immunoreactivity
This pattern warrants reassessment rather than automatic dose escalation
calculating concentration per milliliter